Home » Newsletters » BioWorld Science

BioWorld Science

April 10, 2015

View Archived Issues

Bristol-Myers Squibb presents CETP inhibitor

Merck & Co. reports development of potent gamma-secretase inhibitors

Ono Pharmaceutical reveals new S1P2 antagonists

New role for S100A4 as a biomarker of metastasis in signet-ring cell carcinoma

Merck & Co. patents HIV integrase inhibitors

Vernalis reports development of PDK inhibitors

Tetra Discovery Partners discloses PDE4 inhibitors

Triolimus fixed-dose combination receives FDA orphan drug designation for angiosarcoma

Calitor Sciences and Sunshine Lake Pharma develop PI3Kdelta inhibitors

CRISPR Therapeutics establishes R&D operations in Massachusetts

Mylan proposes to acquire Perrigo

Bristol-Myers Squibb completes acquisition of Flexus Biosciences

Panther Biotechnology to acquire technology assets of Faulk Pharmaceuticals

New Drosophila model of nephrolithiasis presented

AstraZeneca selects first microRNA from Regulus Therapeutics alliance for clinical development

ADXS-HPV to be added to chemotherapy and radiotherapy in phase II/III anal cancer trial

World Parkinson's Day: Mitomycin-treated ESCs show potential

Novel sGC stimulator shows potent antihypertensive effects

FDA accepts lifitegrast NDA for dry eye and grants priority review status

MedImmune's anti-RSV antibody MEDI-8897 receives FDA fast track designation

Santhera's idebenone given FDA fast track designation for DMD

Merus achieves milestone in bispecific antibody collaboration with Ono

Advanced Proteome Therapeutics discloses anticancer activity of immunotherapy combinations

FDA grants fast track designation to cabozantinib for advanced RCC

Agenus acquires Celexion antibody discovery assets

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...